His scientific interests lie mostly in Pharmacology, Internal medicine, Endocrinology, Biochemistry and Tetrahydroisoquinoline. Shigeru Ohta combines subjects such as In vitro, Aldehyde oxidase, Endogeny, Parkinsonism and Neuroscience with his study of Pharmacology. Shigeru Ohta conducts interdisciplinary study in the fields of Endocrinology and Tetrabromobisphenol A through his research.
His study brings together the fields of Tributyltin and Biochemistry. The study incorporates disciplines such as Blood–brain barrier, Parkinson's disease, MPTP, Pathology and Isoquinoline in addition to Tetrahydroisoquinoline. His studies in Metabolite integrate themes in fields like Microsome and Urine.
His primary areas of study are Biochemistry, Pharmacology, Internal medicine, Endocrinology and Metabolism. Microsome, Cytochrome P450, Enzyme, Aldehyde oxidase and Oxidase test are the primary areas of interest in his Biochemistry study. His research integrates issues of Stereochemistry and Reductase in his study of Microsome.
His biological study spans a wide range of topics, including Endogeny, Toxicity and In vivo. Many of his studies on Endocrinology apply to Gene expression as well. Shigeru Ohta has included themes like Metabolite and Pharmacokinetics in his Metabolism study.
Shigeru Ohta spends much of his time researching Pharmacology, Biochemistry, Cytochrome P450, Drug metabolism and Cell biology. His studies deal with areas such as Metabolite, Aldehyde oxidase, Receptor and In vivo as well as Pharmacology. When carried out as part of a general Biochemistry research project, his work on Microsome, Metabolism and Enzyme is frequently linked to work in Predictability, therefore connecting diverse disciplines of study.
Internal medicine and Endocrinology are the focus of his Cytochrome P450 studies. His Internal medicine research focuses on Incubation and how it connects with Transcriptional activity and Rat liver microsomes. His study in Cell biology is interdisciplinary in nature, drawing from both Tributyltin, Triiodothyronine, Transgene, Xenopus and Autophagosome.
Shigeru Ohta mainly investigates Pharmacology, Biochemistry, Drug metabolism, Microsome and Endocrinology. The Pharmacology study combines topics in areas such as Steady state and Single species. His Biochemistry research incorporates themes from Tributyltin, Toxicity and Cell biology.
His Drug metabolism study combines topics in areas such as In vitro, Transplantation, Aldehyde oxidase, Cytochrome P450 and In vivo. Shigeru Ohta has researched Microsome in several fields, including Ether, Triclosan, Carboxylesterase and Metabolism. His Endocrinology study combines topics from a wide range of disciplines, such as Glutamate receptor, Neurotoxicity, Internal medicine and Incubation.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: